Back to mobile site

BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform

October 27, 2023 4:05 AM EDT Send to a Friend
(Updated - October 27, 2023 4:05 AM EDT)

BMO Capital analyst Evan David Seigerman downgraded Bristol-Myers Squibb Co. (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login